Emerging research highlights profound interactions between drug use and microbiome dynamics with implications for diagnostics and treatment. A large Estonian cohort study found that various medications, including antibiotics and non-antibiotic drugs, have lasting effects on gut microbiome composition, persisting years after use, underscoring the need for considering medication history in microbiome studies. Meanwhile, Scanogen is developing rapid multiplex diagnostic panels for bloodstream infections, significantly reducing pathogen identification time from days to hours, enhancing clinical decision-making in sepsis management.